BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7700927)

  • 21. [M-CSF levels during peripheral blood stem cell harvest and autologous stem cell transplantation].
    Saigo K; Sugimoto T; Narita H; Ryo R; Matsui T; Yamamoto M; Kumagai S
    Rinsho Byori; 2000 Jan; 48(1):49-53. PubMed ID: 10756675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stem cell separation with different cell separators].
    Eckstein R; Weisbach V; Zeiler T; Holfeld-Ozuysal C; Zimmermann R; Heuft HG; Zingsem J
    Beitr Infusionsther; 1991; 28():247-50. PubMed ID: 1725630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell transfusion from long-term marrow culture.
    Charbord P
    Transfus Sci; 1992; 13(4):407-13. PubMed ID: 10150139
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors for PBPC collection efficiency and collection predictors.
    Ikeda K; Kozuka T; Harada M
    Transfus Apher Sci; 2004 Dec; 31(3):245-59. PubMed ID: 15556472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
    Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
    Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow processing for transplantation using a Fenwal CS3000 Plus cell separator and a revised version of the Georgetown University procedure: comparison with a starch sedimentation method.
    Smith RJ; Roath S
    Prog Clin Biol Res; 1994; 389():705-10. PubMed ID: 7700938
    [No Abstract]   [Full Text] [Related]  

  • 27. Peripheral blood stem cell transplantation: approaches to an optimal blood stem cell collection.
    Coffe C; Couteret Y; Devillers M; Fest T; Morel P; Pouthier-Stein F; Calot JP; Novakovitch G; Sitthy X; Tremisi PJ
    Transfus Sci; 1992; 13(4):387-98. PubMed ID: 10147737
    [No Abstract]   [Full Text] [Related]  

  • 28. Purging: elimination of malignant cells from autologous blood or marrow transplants.
    Champlin R
    Curr Opin Oncol; 1996 Mar; 8(2):79-83. PubMed ID: 8727298
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage and transfusion of autologous red blood cells from bone marrow harvest.
    Janssen WE; Benson K; Lee C; Noll L; Smilee R; Fields KK; Zorsky PE; Elfenbein GJ
    Prog Clin Biol Res; 1992; 377():337-44. PubMed ID: 1438429
    [No Abstract]   [Full Text] [Related]  

  • 31. Autologous blood stem cell versus bone marrow transplantation.
    Körbling M; Juttner C; Henon P; Kessinger A
    Bone Marrow Transplant; 1992; 10 Suppl 1():144-8. PubMed ID: 1355683
    [No Abstract]   [Full Text] [Related]  

  • 32. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
    Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
    J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term cryopreservation of bone marrow for autologous transplantation.
    Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
    Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditions for optimal cryopreservation of peripheral stem cells.
    Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; de Vries-van Rossen A; Vos A; Zadurian A
    Prog Clin Biol Res; 1994; 389():649-56. PubMed ID: 7700932
    [No Abstract]   [Full Text] [Related]  

  • 37. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
    To LB
    Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous blood transfusion for pediatric bone marrow donors.
    Chan KW; Herd SL; Stanley CE; Wadsworth LD
    Bone Marrow Transplant; 1992 May; 9(5):365-7. PubMed ID: 1617320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentration of large volume peripheral blood stem cell products using the COBE 2991.
    Eby LL; Schepers KG; Shulman-Roskes EM; Noga SJ; Davis JM
    Prog Clin Biol Res; 1994; 389():631-7. PubMed ID: 7700929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.